A1M Pharma's IPO

A1M Pharma raised a round of funding on June 20, 2017. Investors include Public.

A1M Pharma is a biotechnology company that develops and commercializes medical applications based on the endogenous protein A1M. The company's current main focus is kidney protection in connection wit…

Articles about A1M Pharma's IPO: